These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38010775)

  • 21. Coronary CT angiography-derived quantitative markers for predicting in-stent restenosis.
    Tesche C; De Cecco CN; Vliegenthart R; Duguay TM; Stubenrauch AC; Rosenberg RD; Varga-Szemes A; Bayer RR; Yang J; Ebersberger U; Baquet M; Jochheim D; Hoffmann E; Steinberg DH; Chiaramida SA; Schoepf UJ
    J Cardiovasc Comput Tomogr; 2016; 10(5):377-83. PubMed ID: 27431607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between estimated glucose disposal rate and in-stent restenosis following percutaneous coronary intervention in individuals with non-ST-segment elevation acute coronary syndrome.
    Liu C; Zhao Q; Zhao Z; Ma X; Xia Y; Sun Y; Zhang D; Liu X; Zhou Y
    Front Endocrinol (Lausanne); 2022; 13():1033354. PubMed ID: 36452320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and validation of a risk prediction nomogram for in-stent restenosis in patients undergoing percutaneous coronary intervention.
    He W; Xu C; Wang X; Lei J; Qiu Q; Hu Y; Luo D
    BMC Cardiovasc Disord; 2021 Sep; 21(1):435. PubMed ID: 34521385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CHA
    Zhao SG; Xu JJ; Tao ZH; Jin L; Liu Q; Zheng WY; Jiang LQ; Wang NF
    J Int Med Res; 2019 Jun; 47(6):2533-2544. PubMed ID: 31039653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up.
    Zhao LP; Xu WT; Wang L; Li H; Shao CL; Gu HB; Chan SP; Xu HF; Yang XJ
    Coron Artery Dis; 2015 Jan; 26(1):5-10. PubMed ID: 25211654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
    Zhao K; Li YJ; Gao S
    Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and risk factors of in-stent restenosis after percutaneous coronary intervention in patients from southern China.
    Li M; Hou J; Gu X; Weng R; Zhong Z; Liu S
    Eur J Med Res; 2022 Jan; 27(1):12. PubMed ID: 35065663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Nutritional Index as a Novel Predictor of In-Stent Restenosis: A Retrospective Study.
    Balun A; Akgümüş A; Özbek K; Güven Çetin Z
    Medicina (Kaunas); 2023 Mar; 59(4):. PubMed ID: 37109621
    [No Abstract]   [Full Text] [Related]  

  • 29. Platelet Distribution Width on Admission Predicts In-Stent Restenosis in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Treated with Percutaneous Coronary Intervention.
    Hu CP; Du Y; Zhu Y; Shi C; Qin Z; Zhao YX
    Chin Med J (Engl); 2018 Apr; 131(7):757-763. PubMed ID: 29578117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visit-to-visit HbA
    Yang CD; Shen Y; Lu L; Yang ZK; Hu J; Zhang RY; Shen WF; Ding FH; Wang XQ
    Cardiovasc Diabetol; 2020 Sep; 19(1):133. PubMed ID: 32887588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment effect of metformin combined with atorvastatin in reducing in-stent restenosis after percutaneous coronary intervention in coronary artery disease patients with type 2 diabetic patients.
    Chen M; Ma F; Su B; Wang C; Zheng Q; Zhang Y; Li M; Liu S; Zhang S; Yuan L
    Medicine (Baltimore); 2022 Oct; 101(41):e31107. PubMed ID: 36254086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between uric acid to albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting.
    Liu W; Ding K; Bao J; Hu Y; Gui Y; Ye L; Wang L
    Coron Artery Dis; 2023 Dec; 34(8):589-594. PubMed ID: 37855441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Albumin to globulin ratio was associated with in-stent restenosis and revascularization events after percutaneous coronary intervention.
    Zhang R; Tao Z; Gong J; Ji Z; Yang M; Ma G; Li Y
    Clin Transl Sci; 2022 May; 15(5):1187-1195. PubMed ID: 35195938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical analysis of lectin-like oxidized low-density lipoprotein receptor-1 in patients with in-stent restenosis after percutaneous coronary intervention.
    Liu J; Liu Y; Jia K; Huo Z; Huo Q; Liu Z; Li Y; Han X; Wang R
    Medicine (Baltimore); 2018 Apr; 97(17):e0366. PubMed ID: 29702981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravascular Ultrasound and Angiographic Predictors of In-Stent Restenosis of Chronic Total Occlusion Lesions.
    Kang J; Cho YS; Kim SW; Park JJ; Yoon YE; Oh IY; Yoon CH; Suh JW; Youn TJ; Chae IH; Choi DJ
    PLoS One; 2015; 10(10):e0140421. PubMed ID: 26465755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic assessment of the left main-left circumflex bending angle: Implications for ostial left circumflex artery in-stent restenosis after successful two-stent PCI.
    Wang Z; Yang J; Li C; Huang J; Fezzi S; Chen E; Cai W; Stankovic G; Wijns W; Chen L; Tu S
    Int J Cardiol; 2023 May; 378():11-19. PubMed ID: 36796487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-alcoholic fatty liver disease and risk of in-stent restenosis after bare metal stenting in native coronary arteries.
    Shi KQ; Wu FL; Liu WY; Zhao CC; Chen CX; Xie YY; Wu SJ; Lin XF; Chen YP; Wong DK; Yuen MF; Zheng MH
    Mol Biol Rep; 2014 Jul; 41(7):4713-20. PubMed ID: 24691745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atherogenic Index of Plasma and the Risk of In-Stent Restenosis in Patients with Acute Coronary Syndrome beyond the Traditional Risk Factors.
    Zhu Y; Chen M; Liu K; Gao A; Kong X; Liu Y; Han H; Li H; Zhu H; Zhang J; Zhao Y
    J Atheroscler Thromb; 2022 Aug; 29(8):1226-1235. PubMed ID: 34497172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin type 1 receptor A1166C gene polymorphism is associated with endothelial dysfunction and in-stent restenosis after percutaneous coronary intervention.
    Li Y; Chen F; Zhang X; Gao Y; Wu C; Li H; Zhang Y
    Int J Clin Exp Pathol; 2015; 8(6):7350-7. PubMed ID: 26261635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Euonymine inhibits in-stent restenosis through enhancing contractile phenotype of vascular smooth muscle cells via modulating the PTEN/AKT/mTOR signaling pathway.
    Zhang L; Tao Y; Yang R; Hu Q; Jia J; Yu M; He B; Shen Z; Qin H; Yu Z; Chen P
    Phytomedicine; 2022 Dec; 107():154450. PubMed ID: 36174454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.